insulin glargine Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: Adjust insulin dose according to fasting plasma glucose (FBG), Basaglar, Lantus, Semglee, Toujeo

Pipeline

Phase 3: 2Phase 4: 2

Top Sponsors

The First Affiliated Hospital of Xiamen University1
Novo Nordisk A/S1
Nanjing First Hospital, Nanjing Medical University1
Loyola University1

Indications

Diabetes4
Type 2 Diabetes Patients1
Gestational Diabetes Mellitus, Class A21
Diabetes Mellitus in Pregnancy1
Hyperglycaemia (Diabetic)1

Other2 trials

Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes

Phase 4

Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)

Phase 4

Cullman, Alabama1 trial

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

Cullman Clinical Trials

Phase 3

Maywood, Illinois1 trial

RCT Glargine vs NPH for Treatment of DM in Pregnancy

Loyola University Medical Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.